Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$739M |
| 2 |
Progressive
PGR
|
+$435M |
| 3 |
Danaher
DHR
|
+$362M |
| 4 |
Revvity
RVTY
|
+$314M |
| 5 |
Netflix
NFLX
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$648M |
| 2 |
Microsoft
MSFT
|
+$569M |
| 3 |
AbbVie
ABBV
|
+$406M |
| 4 |
NVIDIA
NVDA
|
+$351M |
| 5 |
Eli Lilly
LLY
|
+$350M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.65% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.08% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Anavex Life Sciences
AVXL
$238M
| $262K | ﹤0.01% |
32,265
-25
| -0.1% | -$214 |
|
2327
Evolv Technologies
EVLV
$1.01B
| $262K | ﹤0.01% |
43,665
+26,966
| +161% | +$128K |
|
2328
Conduent
CNDT
$251M
| $259K | ﹤0.01% |
76,122
+79
| +0.1% | +$259 |
|
2329
Theravance Biopharma
TBPH
$875M
| $259K | ﹤0.01% |
24,988
-55
| -0.2% | -$607 |
|
2330
CEVA Inc
CEVA
$883M
| $258K | ﹤0.01% |
10,104
-11
| -0.1% | -$277 |
|
2331
Five Star Bancorp
FSBC
$1.02B
| $258K | ﹤0.01% |
+11,545
| New | +$234K |
|
|
PFC
2332
DELISTED
Premier Financial Corp. Common Stock
PFC
| $258K | ﹤0.01% |
16,094
-19
| -0.1% | -$312 |
|
2333
Titan International
TWI
$530M
| $256K | ﹤0.01% |
22,283
-28
| -0.1% | -$297 |
|
2334
Amplitude
AMPL
$1.16B
| $255K | ﹤0.01% |
23,178
+31
| +0.1% | +$334 |
|
2335
Community Trust Bancorp
CTBI
$1.42B
| $254K | ﹤0.01% |
7,155
+4
| +0.1% | +$144 |
|
2336
British American Tobacco
BTI
$134B
| $254K | ﹤0.01% |
7,657
+1,602
| +26% | +$54.8K |
|
2337
Hackett Group
HCKT
$266M
| $252K | ﹤0.01% |
11,293
-48
| -0.4% | -$940 |
|
2338
Titan Machinery
TITN
$458M
| $252K | ﹤0.01% |
8,547
-12
| -0.1% | -$362 |
|
|
FBMS
2339
DELISTED
The First Bancshares, Inc.
FBMS
| $252K | ﹤0.01% |
9,760
-33
| -0.3% | -$845 |
|
2340
Heritage Financial
HFWA
$1.22B
| $252K | ﹤0.01% |
15,544
-19
| -0.1% | -$331 |
|
2341
Editas Medicine
EDIT
$402M
| $251K | ﹤0.01% |
30,511
-37
| -0.1% | -$322 |
|
2342
Xperi
XPER
$368M
| $251K | ﹤0.01% |
19,086
-68
| -0.4% | -$737 |
|
|
MODV
2343
DELISTED
ModivCare
MODV
| $250K | ﹤0.01% |
5,525
-179,090
| -97% | -$10.6M |
|
2344
Allient
ALNT
$1.42B
| $249K | ﹤0.01% |
6,230
-10
| -0.2% | -$364 |
|
|
ME
2345
DELISTED
23andMe Holding Co
ME
| $248K | ﹤0.01% |
7,113
+3,925
| +123% | +$156K |
|
|
TRST
2346
Trustco Bank Corp NY
TRST
$984M
| $248K | ﹤0.01% |
8,680
-11
| -0.1% | -$323 |
|
2347
REX American Resources
REX
$1.4B
| $248K | ﹤0.01% |
14,270
-18
| -0.1% | -$279 |
|
2348
York Water
YORW
$517M
| $248K | ﹤0.01% |
6,014
-8
| -0.1% | -$347 |
|
2349
Health Catalyst
HCAT
$158M
| $248K | ﹤0.01% |
19,808
-25
| -0.1% | -$298 |
|
|
FPI
2350
Farmland Partners
FPI
$417M
| $248K | ﹤0.01% |
20,286
-43
| -0.2% | -$481 |
|
Similar funds
Janus Henderson Group's Q2 2023 Portfolio in Review
As of Q2 2023, Janus Henderson Group held 2,758 positions worth $161B, up 6% from $152B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q2 2023 filing shows 73 new, 782 increased, 1,689 reduced and 166 closed positions. Its largest new stake was ATS Corp: 1,554,233 shares worth $71.6M. The largest sale was Advanced Micro Devices, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q2 2023 buy was ATS Corp: 1,554,233 shares worth $71.6M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q2 2023, an estimated $739M increase.
- Janus Henderson Group's biggest Q2 2023 reduction was Advanced Micro Devices, cutting an estimated $648M.
- Janus Henderson Group fully exited Warner Music in Q2 2023, selling an estimated $50.6M.
- Janus Henderson Group's ten largest holdings make up 24% of its $161B portfolio in Q2 2023.
- Janus Henderson Group opened 73 new positions and closed 166 in Q2 2023.
- Janus Henderson Group's portfolio value rose 6% quarter-over-quarter to $161B.
Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.